ASH 2021: A Multiple Myeloma Roundtable Discussion

ASH 2021: Deep Dive into Current and Future Myeloma Treatments

What Are the Current and Emerging Treatments for Multiple Myeloma?

Follow along as multiple myeloma experts Noopur Raje, MD, and Joshua Richter, MD, meet with Patient Power co-founder Andrew Schorr for a roundtable discussion about American Society of Hematology (ASH) conference updates in multiple myeloma treatment. They cover new findings in personalized medicine, sequencing studies that discover abnormalities, and the specific drugs used to target them. Dr. Raje is the Director of the Center for Multiple Myeloma at the Massachusetts General Hospital Cancer Center. Dr. Richter is an Associate Professor of Medicine at Mount Sinai.

Support for this program has been provided by Janssen Oncology. Patient Power maintains complete editorial control and is solely responsible for program content.

This article was originally published December 20, 2021 and most recently updated December 23, 2021.
© 2024 HealthCentral LLC. All rights reserved.